Long-Term Outcomes of Congenital Adrenal Hyperplasia

Overview

Journal Endocrinol Metab (Seoul)

Specialty Endocrinology

Date 2022 Jul 8

PMID 35799332

Authors

Anna Nordenstrom

Svetlana Lajic

Henrik Falhammar

Affiliations

Soon will be listed here.

Abstract

A plethora of negative long-term outcomes have been associated with congenital adrenal hyperplasia (CAH). The causes are multiple and involve supra-physiological gluco- and mineralocorticoid replacement, excess adrenal androgens both intrauterine and postnatal, elevated steroid precursor and adrenocorticotropic hormone levels, living with a congenital condition as well as the proximity of the cytochrome P450 family 21 subfamily A member 2 (CYP21A2) gene to other genes. This review aims to discuss the different long-term outcomes of CAH.

Citing Articles

Genetics in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency and Clinical Implications.

Concolino P, Falhammar H J Endocr Soc. 2025; 9(3):bvaf018.

PMID: 39911519 PMC: 11795198. DOI: 10.1210/jendso/bvaf018.

Challenges in Adolescent and Adult Males With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

Claahsen-van der Grinten H, Adriaansen B, Falhammar H J Clin Endocrinol Metab. 2025; 110(Supplement_1):S25-S36.

PMID: 39836620 PMC: 11749911. DOI: 10.1210/clinem/dgae718.

Exploring the Differential Diagnosis of Adrenal Adenoma in the Context of Situs Ambiguous: A Clinical Case Study.

Stanchev P, Dimitrova M, Makakova D, Tilov B Medicina (Kaunas). 2025; 60(12.

PMID: 39768890 PMC: 11727780. DOI: 10.3390/medicina60122010.

Cardiometabolic Aspects of Congenital Adrenal Hyperplasia.

Krysiak R, Claahsen-van der Grinten H, Reisch N, Touraine P, Falhammar H Endocr Rev. 2024; 46(1):80-148.

PMID: 39240753 PMC: 11720181. DOI: 10.1210/endrev/bnae026.

Contexts of care for people with differences of sex development: Diversity is still missing in the laboratory routine.

Kulle A, Jurgensen M, Dohnert U, Malich L, Marshall L, Hiort O Med Genet. 2024; 35(3):181-187.

PMID: 38840817 PMC: 10842577. DOI: 10.1515/medgen-2023-2037.

References

Tamhane S, Rodriguez-Gutierrez R, Mohamed Iqbal A, Prokop L, Bancos I, Speiser P . Cardiovascular and Metabolic Outcomes in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2018; 103(11):4097-4103. DOI: 10.1210/jc.2018-01862. View

Bonfig W, Roehl F, Riedl S, Dorr H, Bettendorf M, Bramswig J . Blood Pressure in a Large Cohort of Children and Adolescents With Classic Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency. Am J Hypertens. 2015; 29(2):266-72. DOI: 10.1093/ajh/hpv087. View

Torky A, Sinaii N, Jha S, Desai J, El-Maouche D, Mallappa A . Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab. 2021; 106(12):e5247-e5257. PMC: 8864751. DOI: 10.1210/clinem/dgab133. View

Labarta E, Martinez-Conejero J, Alama P, Horcajadas J, Pellicer A, Simon C . Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod. 2011; 26(7):1813-25. DOI: 10.1093/humrep/der126. View

Rushworth R, Chrisp G, Bownes S, Torpy D, Falhammar H . Adrenal crises in adolescents and young adults. Endocrine. 2022; 77(1):1-10. PMC: 9242908. DOI: 10.1007/s12020-022-03070-3. View

Falhammar H, Wedell A, Nordenstrom A . Biochemical and genetic diagnosis of 21-hydroxylase deficiency. Endocrine. 2015; 50(2):306-14. DOI: 10.1007/s12020-015-0731-6. View

Muthusamy K, Elamin M, Smushkin G, Murad M, Lampropulos J, Elamin K . Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2010; 95(9):4161-72. DOI: 10.1210/jc.2009-2616. View

Finkielstain G, Kim M, Sinaii N, Nishitani M, Van Ryzin C, Hill S . Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2012; 97(12):4429-38. PMC: 3513542. DOI: 10.1210/jc.2012-2102. View

Burger-Stritt S, Kardonski P, Pulzer A, Meyer G, Quinkler M, Hahner S . Management of adrenal emergencies in educated patients with adrenal insufficiency-A prospective study. Clin Endocrinol (Oxf). 2018; 89(1):22-29. DOI: 10.1111/cen.13608. View

10.

Sciannamblo M, Russo G, Cuccato D, Chiumello G, Mora S . Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2006; 91(11):4453-8. DOI: 10.1210/jc.2005-2823. View

11.

Gao Y, Lu L, Yu B, Mao J, Wang X, Nie M . The Prevalence of the Chimeric TNXA/TNXB Gene and Clinical Symptoms of Ehlers-Danlos Syndrome with 21-Hydroxylase Deficiency. J Clin Endocrinol Metab. 2020; 105(7). DOI: 10.1210/clinem/dgaa199. View

12.

Kocova M, Anastasovska V, Falhammar H . Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine. 2020; 69(2):262-277. PMC: 7392929. DOI: 10.1007/s12020-020-02323-3. View

13.

Falhammar H, Nordenstrom A . Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome. Endocrine. 2015; 50(1):32-50. DOI: 10.1007/s12020-015-0656-0. View

14.

Claahsen-van der Grinten H, Speiser P, Ahmed S, Arlt W, Auchus R, Falhammar H . Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management. Endocr Rev. 2021; 43(1):91-159. PMC: 8755999. DOI: 10.1210/endrev/bnab016. View

15.

Burman P, Falhammar H, Waldenstrom E, Sundin A, Bitzen U . 11C-Metomidate PET/CT Detected Multiple Ectopic Adrenal Rest Tumors in a Woman With Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab. 2020; 106(2):e675-e679. DOI: 10.1210/clinem/dgaa870. View

16.

Nygren U, Sodersten M, Thyen U, Kohler B, Nordenskjold A . Voice dissatisfaction in individuals with a disorder of sex development. Clin Endocrinol (Oxf). 2019; 91(1):219-227. DOI: 10.1111/cen.14000. View

17.

Kannel W, Kannel C, Paffenbarger Jr R, Cupples L . Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J. 1987; 113(6):1489-94. DOI: 10.1016/0002-8703(87)90666-1. View

18.

Daae E, Feragen K, Nermoen I, Falhammar H . Psychological adjustment, quality of life, and self-perceptions of reproductive health in males with congenital adrenal hyperplasia: a systematic review. Endocrine. 2018; 62(1):3-13. PMC: 6153586. DOI: 10.1007/s12020-018-1723-0. View

19.

Whittle E, Falhammar H . Glucocorticoid Regimens in the Treatment of Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis. J Endocr Soc. 2019; 3(6):1227-1245. PMC: 6546346. DOI: 10.1210/js.2019-00136. View

20.

Espinosa Reyes T, Mesa T, Lantigua Cruz P, Agramonte Machado A, Dominguez Alonso E, Falhammar H . Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. BMC Endocr Disord. 2020; 20(1):165. PMC: 7653887. DOI: 10.1186/s12902-020-00643-z. View